The stock of Chemours Co (NYSE:CC) hit a new 52-week high and has $26.45 target or 64.00% above today’s $16.13 share price. The 5 months bullish chart indicates low risk for the $3.04 billion company. The 1-year high was reported on Oct, 19 by Barchart.com. If the $26.45 price target is reached, the company will be worth $1.95B more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 1.37 million shares traded hands. Chemours Co (NYSE:CC) has risen 137.07% since March 16, 2016 and is uptrending. It has outperformed by 131.53% the S&P500.
Analysts await Chemours Co (NYSE:CC) to report earnings on November, 3. They expect $0.26 earnings per share, down 35.00% or $0.14 from last year’s $0.4 per share. CC’s profit will be $49.00 million for 15.51 P/E if the $0.26 EPS becomes a reality. After $0.27 actual earnings per share reported by Chemours Co for the previous quarter, Wall Street now forecasts -3.70% negative EPS growth.
Chemours Co (NYSE:CC) Ratings Coverage
Out of 8 analysts covering Chemours (NYSE:CC), 3 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 38% are positive. Chemours has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. On Tuesday, August 18 the stock rating was downgraded by UBS to “Sell”. The firm earned “Neutral” rating on Friday, August 14 by Citigroup. JP Morgan upgraded the shares of CC in a report on Friday, August 7 to “Underweight” rating. The rating was maintained by Citigroup with “Neutral” on Thursday, August 11. On Thursday, September 1 the stock rating was maintained by Jefferies with “Hold”. Jefferies downgraded Chemours Co (NYSE:CC) on Tuesday, February 16 to “Hold” rating. The firm has “Sell” rating given on Tuesday, August 9 by UBS. On Monday, April 18 the stock rating was maintained by Citigroup with “Neutral”. The stock of Chemours Co (NYSE:CC) earned “Hold” rating by Argus Research on Friday, September 18. Argus Research upgraded the stock to “Buy” rating in Wednesday, August 10 report.
According to Zacks Investment Research, “Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company’s brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.”
More important recent Chemours Co (NYSE:CC) news were published by: Fool.com which released: “Chemours Co Surges After New Jury Verdict” on July 08, 2016, also Valuewalk.com published article titled: “Chemours Co (CC) â€œMost Morally And Financially Bankrupt Companyâ€ Ever: Citron …”, Valuewalk.com published: “Chemours Co (CC) Starts To Rally After Tanking On Wednesday” on July 07, 2016. More interesting news about Chemours Co (NYSE:CC) was released by: Fool.com and their article: “Here’s Why Chemours Co Stock Popped Today” with publication date: February 24, 2016.
CC Company Profile
The Chemours Company, incorporated on February 18, 2014, is a well-known provider of performance chemicals. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment produces titanium dioxide (TiO2). The Company’s Fluoroproducts segment provides fluoroproducts, such as refrigerants and industrial fluoropolymer resins. The Company’s Chemical Solutions segment provides industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers and other industries. The Firm operates approximately 30 production facilities located in over 10 countries and serves a range of end markets in over 130 countries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.